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2Abstract1
Human primordial germ cells (hPGCs), the precursors of sperm and eggs,2
originate during week 2-3 of early postimplantation development1. Using in3
vitro models of hPGC induction2-4, recent studies suggest striking4
mechanistic differences in specification of human and mouse PGCs5. This5
may partly be due to the divergence in their pluripotency networks, and6
early postimplantation development6-8. Since early human embryos are7
inaccessible for direct studies, we considered alternatives, including8
porcine embryos that, as in humans, develop as bilaminar embryonic9
discs. Here we show that porcine PGCs (pPGCs) originate from the10
posterior pre-primitive streak competent epiblast by sequential11
upregulation of SOX17 and BLIMP1 in response to WNT and BMP12
signalling. Together with human and monkey in vitro models simulating13
peri-gastrulation development, we show conserved principles for epiblast14
development for competency for PGC fate, followed by initiation of the15
epigenetic program9-11, regulated by a balanced SOX17–BLIMP1 gene16
dosage. Our combinatorial approach using human, porcine and monkey in17
vivo and in vitro models, provides synthetic insights on early human18
development.19
20
21
3First, we sought the origin of porcine PGCs (pPGCs) in ~E9.5-E16 peri-gastrulating1
embryos. At ~E9.5–E10, key pluripotency genes NANOG, OCT4 and SOX2 are2
detected in the epiblast of bilaminar embryos (Fig. 1a). In ~E11 pre-primitive streak3
(PS) stage embryos with an incipient anterior-posterior axis (Extended Data Fig. 1a),4
BRACHYURY (T) expression is evident in the posterior pseudo-stratified epiblast cells,5
together with NANOG and OCT4, but SOX2 is downregulated (Fig. 1b).6
7
In the midline of early-PS stage embryos (~E11.5-E12), we see the first cluster of8
SOX17 positive (+ve) cells in the posterior end of the nascent PS (arrows in Fig. 1c,d;9
Extended Data Fig. 1b); most of these express BLIMP1, except for those at the10
anterior end. Expression of SOX17 precedes BLIMP1; NANOG is retained with11
upregulation occurring in SOX17/BLIMP1 +ve pPGCs (Fig. 1d; Extended Data Fig.12
1b). In ~E12.5-E13.5 embryos, pPGCs exhibit co-expression of SOX17, BLIMP1,13
NANOG, TFAP2C, OCT4, and pPGC cell surface marker Sda/GM212, but have low14
levels of T (Fig. 1e, Extended Data Fig. 1c,d). This pPGC cluster of ~6015
SOX17/BLIMP1 +ve cells located at the border between embryonic and extraembryonic16
tissues in early-PS stage embryos (~E12), increases to >300 PGCs by ~E15.517
(Extended Data Fig. 2a-c). A 6-hour (h) pulse of EdU labelling shows that DNA18
synthesis ceases soon after the detection of Sda/GM2 epitope (Fig. 1f, Extended Data19
Fig.2d). This indicates that the sharp increase in their number is likely due to the20
recruitment of additional pPGCs from T+ve competent progenitors. Thereafter, pPGCs21
enter quiescence and pause prior to migration, as in mice13 (Fig. 1f, Extended Data Fig.22
2c). Notably, PRDM14 expression in pPGCs is weak and apparently cytoplasmic23
(Extended Data Fig. 1f), while SOX2 is undetectable (Extended Data Fig. 2e,f).24
41
Initiation of the germline-specific epigenetic program9,14 is evident in nascent pPGCs2
with a global reduction in 5-methylcytosine (5mC) (Extended Data Fig. 3b,c) and3
concomitant enrichment of 5-hydroxymethylcytosine (5hmC) (Fig. 1g,h). Consistently,4
UHRF1 is downregulated (Fig. 1i) and TET1 is upregulated (Extended Data Fig. 3a).5
Progressive reduction in H3K9me2 and G9a expression is also evident (Extended Data6
Fig. 3b,c) and global DNA demethylation follows as pPGCs migrate towards the gonads7
(Extended Data Fig. 3d). Expression of SOX17, BLIMP1, TFAP2C, OCT4 and NANOG8
continues in pPGCs (arrowheads in Fig. 1e, Extended Data Fig. 2e,f), as seen in9
equivalent hPGCs in vivo4,9. Thus the key features of early pPGCs from their origin in10
peri-gastrulation porcine epiblast has close similarities with hPGCs following sequential11
SOX17 and BLIMP1 expression, and the onset of the epigenetic program4,9.12
13
To determine when porcine epiblasts gain competency for pPGC fate, we isolated14
epiblast discs away from the hypoblast and trophectoderm at different stages of15
development (Fig. 2a,b,d,e). We exposed them to cytokines, including BMP2 or16
43,4(henceforth called Cytokines or Cy) for 64h to induce pPGCs ex vivo (Fig. 2f). While17
no response was seen in ~E10.5-E11 early bilaminar disc epiblasts, an efficient18
induction of pPGCs occurs in epiblasts from ~E11.5 pre-PS stage embryos, as judged19
by co-expression of three of SOX17, BLIMP1, NANOG, OCT4 and TFAP2C (Fig. 2g,h,20
Extended Data Fig. 3e). Note a strong BMP2/4 signal from the posterior pre-streak and21
early PS pig embryos in vivo15,16 (Fig. 2a), with nuclear pSMAD1/5/8 localisation in the22
posterior epiblast (Fig. 2c). BMP4 inhibitor (LDN193189) abrogates (0/5) pPGC23
induction (Fig. 2g, Extended Data Fig. 3e). The competency for pPGC fate wanes24
5during early-PS stage concomitantly with the onset of gastrulation and mesendoderm1
differentiation (Fig. 1c). WNT signalling from the posterior pre-PS epiblast is also2
apparently important (Fig. 2a), as evidenced by the high proportion of T +ve cells, a3
downstream target on WNT17, at the onset of pPGC induction (Fig. 1b). A WNT inhibitor4
(WNTi) diminishes pPGC induction at this time, but has no effect on early-PS stage5
epiblast when they are already competent for pPGC fate (Fig. 2g, Extended Data6
Fig.3e). Expression of T in response to WNT is a common feature of competency for7
germ cell fate3,4,17.8
Next, since we cannot examine early human embryos directly, we decided to simulate9
human peri-gastrulation development and induce hPGC fate in vitro. We established an10
in vitro model with human pluripotent stem cells (hPSC) for mesendoderm (ME) and11
peri-gastrulation development18-20 (Fig. 3a). These hPSCs maintained in a defined12
conventional medium (henceforth; Conv-hPSCs, see Methods), are probably13
equivalent to the pre-gastrulating porcine epiblast21. To follow gain and loss of14
competency for hPGCs in the course of ME differentiation, we used cells with a15
sensitive NANOS3-tdTomato (NT) reporter to assess hPGC induction efficiency (see16
Extended Data Fig. 4). We induced hPGCs at 6h intervals by Cytokines (Fig. 3a) and17
observed a peak of competency for hPGC fate at ~12h during ME differentiation, which18
declines thereafter (Fig. 3b,d), illustrating a step-wise transition in cell states.19
Accordingly, competent cells show moderate upregulation of PS markers; T, MIXL,20
GSC, EVX1 and EOMES, and a slight reduction of SOX2 (Fig. 3e, Extended Data Fig.21
5a, b). At 18h onwards, we detect further upregulation of Late PS markers, including22
TBX6, MESP1/2, and SNAIL (SNAI1/2), which triggers epithelial-mesenchymal23
transition, occurring during gastrulation22 (Extended Data Fig. 5b). The response of24
6cells to signalling changes significantly at this time, since BMP2/4 now induces1
mesodermal cells (Extended Data Fig. 5b, e-h), while Activin A and a BMP inhibitor2
induce definitive endoderm (DE) very efficiently18 (Fig. 3c,d. Extended Data Fig. 5e-h).3
Thus, from ~12h, onwards, the precursors of ME (or Pre-ME) are competent for PGC4
fate, but from ~18h (ME), PGC competency is progressively lost, with concomitant gain5
of competency for DE/mesoderm fates (Fig. 3a-c).6
7
We find that both WNT and ACTIVIN/NODAL signalling are necessary for competency8
for hPGCs in Pre-ME at 12h (Extended Data Fig. 5c). Inhibition of BMP signalling9
during ME differentiation dramatically reduces the efficiency of hPGC induction,10
suggesting a role for endogenous BMP in competency for hPGCs (Extended Data Fig.11
5d). Addition of BMP during Pre-ME(12h) however does not affect hPGC competency,12
but it favours differentiation into lateral mesoderm (LM) at 24h, which originates from13
mid/posterior PS (Extended Data Fig. 5e-h). By contrast, DE differentiation occurs in14
the anterior PS as seen in PS-stage porcine embryos (arrowheads in Fig 1d, Extended15
Data Fig.1c), suggesting that BMP confers posterior characteristics to PS during16
gastrulation (Extended Data Fig. 5i). The combined evidence from porcine embryos,17
and simulations in the in vitro model with Conv-hPSCs, shows progressive and transient18
acquisition of competency for hPGC, followed by competency for DE/mesoderm.19
20
To test if this model for hPGC specification applies to non-human primates, we used21
Cynomolgus monkey PSCs (cmPSCs) to induce ME differentiation (Extended Data22
Fig. 6a,b). Remarkably, cmPSCs also show a temporal gain of competency for cmPGC23
fate at ~12h during ME differentiation, and thereafter DE and mesoderm at 24h24
7(Extended Data Fig. 6c-f). A recent study suggests that cmPGCs originate from the1
nascent amnion, although their origin from the posterior epiblast also cannot be2
excluded23; a dual origin from both tissues is however possible. A detailed molecular3
analysis of amnion is important, especially since some PGC genes, such as SOX17 and4
BLIMP1 also have roles elsewhere, including extraembryonic tissues24,25. Further5
traceable analysis on in vivo non-human primate embryo, and potentially on in vitro6
development of human embryos is merited, as well as of other ‘flat disc’ mammalian7
embryos. Note that the extraembryonic tissues display greater diversity and are likely to8
be less developmentally constrained compared to the epiblast26.9
10
Next, we examined the combinatorial roles of the key transcription factors. Since11
SOX17 is the key regulator of both hPGC and DE fates (Fig. 3d)4,27, we tested how it12
induces these two distinct cell fates. Ectopic expression of SOX17 in Pre-ME at 12h13
induces hPGCs resulting in NT/OCT4/BLIMP1+ve cells, but in ME at 24h it induces14
FOXA2+ve (DE) efficiently (Fig. 3f,g). The underlying mechanism for this change in15
response to SOX17 requires further investigation. During the induction of hPGCs in16
Pre-ME by BMP (Extended Data Fig. 7a,b), we first detect SOX17 at 12h, of which17
~30-40% show co-expression with BLIMP1, but not TFAP2C (Extended Data Fig.18
7c,d), as in the pig embryo (Extended Data Fig. 1e). TFAP2C is detected at ~18h, as19
the number of SOX17/BLIMP1/TFAP2c+ve cells increases progressively. These20
putative hPGCs eventually form a cluster in the middle of embryoids by 48h (Extended21
Data Fig. 7b,c,e). At 12h, we see NANOG expression, which increases progressively in22
SOX17/BLIMP1+ve cells at 24h onwards (Extended Data Fig. 7e,f). However, unlike in23
mouse28, NANOG alone cannot induce hPGCs (Extended Data Fig. 8a-c), and24
8PRDM14 expression appears to be weak2,4, and might be cytoplasmic in E14 pPGCs1
(Extended Data Fig. 1f) and in in vivo hPGCs5. Notably, PRDM14 is critical for mouse2
PGC fate and for the initiation of epigenetic reprogramming29. Further studies are3
required to determine what role, if any, PRDM14 has in porcine or human PGCs.4
5
Next, we examined SOX17, BLIMP1 and TFAP2C individually and in combination for6
the induction of hPGCs in the reversibly PGC-competent hPSCs (Comp-hPSC)47
(Extended Data Fig. 4c-j, see Methods). The Comp-hPSC has the NT-reporter, as8
well as inducible SOX17, BLIMP1 and TFAP2C transgenes (Extended Data Fig. 8d-g).9
We find that BLIMP1 and TFAP2C individually and together elicit a negligible response10
after 2 days, while SOX17 alone produces a modest response, which does not change11
when combined with TFAP2C (Fig. 4a). Remarkably, SOX17 with BLIMP1 produce a12
highly accentuated response, resulting in a large proportion of NT-positive cells (Fig.13
4a), suggesting that they act synergistically and rapidly (within ~24h), compared to 96h14
for Cytokines to induce a similar response (Fig. 4b,c). This response is preceded by15
downregulation of SOX230 and upregulation of ‘naïve’ pluripotency genes including16
KLF4 and TFCP2L1, as in hPGCs in vivo9 (Fig. 4e, Extended Data Fig. 8h). The17
response to SOX17-BLIMP1 is otherwise similar to that induced by Cytokines as judged18
by global RNA-seq (Fig. 4d, Extended Data Fig. 8i,j).19
20
For further mechanistic insights, we induced ectopic SOX17 with or without BLIMP121
expression in SOX17 null Comp-hPSC4 (Extended Data Fig. 9a, Extended Data Fig.22
10a,b). Although SOX17 initiates hPGC fate, there is also a significant increase in23
FOXA2 expression, an endodermal gene (Fig. 4f). Accordingly, FACS-purified cells24
9show FOXA1, FOXA2 and HNF1 expression, alongside PGC markers, OCT4,1
NANOG, BLIMP1 and TFAP2C (Extended Data Fig. 9b), and the cell surface marker2
CXCR4 shared by both endoderm19 and PGC in humans (Extended Data Fig. 9c,d).3
This might occur when ectopic SOX17 gene dosage exceeds the levels induced by4
BMP in wildtype Comp-hPSC (Extended Data Fig. 9b, e-h), without a proportionate5
increase in BLIMP1 (Extended Data Fig. 9i); BLIMP1 represses endodermal genes6
during hPGC specification9. Indeed, concomitantly high BLIMP1 and SOX17 induce7
hPGCs robustly and rapidly while suppressing endoderm genes (Fig. 4g, Extended8
Data Fig. 10c). SOX17–BLIMP1 also initiate the germline-specific epigenetic program9;9
accordingly, we observe downregulation of DNMT3A, DNMT3B and UHRF1, and10
upregulation of TET2 (Extended Data Fig. 8k), as in pPGCs (Extended Data Fig.11
3b,d).12
13
The ex vivo peri-gastrulation porcine embryos, and in vitro mimics for human and14
monkey development together exemplify conserved principles for PGC specification in15
the context of epiblast development in flat disc embryos (Fig. 4h). We show how SOX1716
likely regulates both PGCs and DE. We propose that signalling followed by epigenetic17
priming of regulatory elements might confer competency for PGC fate, and thereafter18
DE/mesoderm, as an integral part of epiblast development program towards19
gastrulation. Remarkably, SOX17-BLIMP1 are necessary and sufficient for inducing20
PGCs, and for initiating the germline-specific epigenetic program. Once specified,21
PGCs are irreversibly committed to the germline fate (Extended Data Fig. 2e,f,22
Extended Data Fig. 10d,e). Notably, our integrated approach provides insights on23
early human development and cell fate decisions.24
10
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Main Figure Legends1
Fig.1 Specification of PGCs in gastrulating porcine embryos2
Serial sections with immunostainings:3
a. Bilaminar disc embryo (~E9.5-E10); Arrowhead marks the4
epiblast/trophectoderm boundary. Scale bar: 20 µm.5
b. Pre-primitive streak embryo (Pre-PS; ~E11) . Scale bar: 10 µm.6
c. Early primitive streak embryo (Early-PS; ~E11.5-E12) with SOX17 and7
BLIMP1 expression. Close-up (dashed lines) shows four SOX17 +ve and8
BLIMP1 -ve cells (arrows). Dashed lines highlight SOX17/BLIMP +ve cells. The9
hypoblast is SOX17/BLIMP1 +ve. Scale bar: 10 µm.10
d. Primitive streak embryo (PS; ~E12) with a pPGC cluster showing SOX17 and11
NANOG expression. Four SOX17 +ve cells without NANOG in the most anterior12
pPGC cluster (arrows in middle image). The right most image (arrows) point to13
five SOX17 +ve and BLIMP1 -ve cells. Arrowheads show anterior PS with14
SOX17 +ve definitive endoderm cells. Dashed lines highlight SOX17/BLIMP +ve15
cells. Scale bar: 10 µm. Inset shows the whole embryo.16
e. Late primitive streak embryo (Late-PS; ~E12.5-E13.5) with a pPGC cluster17
(arrow) showing NANOG, SOX17, TFAP2C, BLIMP1, T and Sda/GM218
expression. Arrowheads: early migratory pPGCs. Scale bar: 25 µm.19
A<–>P; anterior-posterior axis20
f. Quantification of EdU incorporation in pPGCs and somatic cells. Numbers21
denote analyzed cells.22
g. Sagittal section of E14.5 embryo immunostained for OCT4 and 5hmC, and23
the pPGC cluster (white square) . Arrows: migratory PGCs. Scale bar: 20 μm. 24
12
h. Quantification of 5hmC.in analyzed cells. (Mann-Whitney: * p<0.01).1
i. Immunostaining for UHRF1 in E14 embryos. Dashed line delimits the pPGC2
cluster. Scale bar: 20 μm.3
4
5
Fig.2 Competence for pPGC specification6
a. Representation of porcine epiblasts and signaling for pPGC induction.7
b. Dissected epiblasts. Scale bar: 0.25 mm.8
c. Serial sections of a Pre-PS embryo showing pSMAD1/5/8 and T. Close-up9
(dashed lines) of posterior epiblast cells (arrows) with nuclear pSMAD but no T.10
Scale bar: 20 μm. 11
d. Epiblasts culture for 64 h.12
e. Epiblasts prior to culture. Scale bar: 0.5mm.13
f. Epiblasts after 64 h culture.14
g. Scatter plot for the triple positive pPGCs staining.15
h. Triple immunostaining of epiblasts. Scale bar: 20 μm.  16
WNTi (WNT inhibitor); BMPi (BMP inhibitor)17
18
19
Fig.3 Simulating of human peri-gastrulation and hPGC competency20
a. Schematics showing progressive gain and loss of competency for hPGCs.21
b. Induction of hPGCs (% NT/AP +ve cells) in day 4-5 embryoids.22
c. Induction of of definitive endoderm (DE: (% CXCR4 +ve cells)) at 12h–24h of23
during ME differentiation.24
13
d. Immunostaining of hPGCs induced from Pre-ME(12h) and of DE from1
ME(24h). Dashed lines: SOX17/OCT4 +ve hPGCs. Scale bar: 50 μm. 2
e. Gene expression (RT-qPCR) changes during ME induction.3
f. Induction of hPGCs (%NANOS3-tdTomato/AP +ve cells) from Pre-ME(12h) or4
ME(24h). Pre-ME are competent for hPGCs in response cytokines or SOX17,5
but ME are not.6
g. Immunostaining of day4 embryoids from Pre-ME(12h) or ME(24h). SOX17 in7
Pre-ME induced OCT4/BLIMP1 +ve hPGCs (dashed line), but in ME, it induced8
DE  (BLIMP1/FOXA2 +ve) cells. Scale bar: 50 μm. 9
10
11
Fig.4 Induction of hPGCs by SOX17-BLIMP1 and combined representation12
of hPGCs and pPGCs specification13
a. Induction of hPGCs by transcription factors in Comp-hPSCs: SOX17-BLIMP114
induce hPGCs15
b. Day1–4 embryoids with NANOS3-tdTomato (NT) reporter respond to ectopic16
SOX17 and BLIMP1 with or without cytokines.17
c. Induction of hPGCs (% NT/AP +ve cells) shown in Fig.4b.18
d. t-SNE analysis of RNA-seq data.19
e. Heat map of representative gene expression includes previous data4.20
f. Day 4 embryoids induced by cytokines. Dashed line indicates positive signals.21
Arrowheads: OCT4/BLIMP1 +ve hPGC expressing FOXA2. Scale bar: 50 μm. 22
g. SOX17 and BLIMP1 gene dosage is critical during hPGC specification:23
BLIMP1 represses SOX17-induced endodermal genes.24
14
h. Representation of human germ cell origin and program based on in vitro1
simulations from hPSCs and in vivo origin of pPGCs in porcine embryos.2
3
15
Extended Data Figure Legends1
Extended Data Fig.1 Expression of key germ cell genes in early pPGCs.2
a. Representation of a mouse, pig and human embryos before gastrulation3
b. Sections of Early-PS and PS stage embryo showing SOX17, BLIMP1,4
NANOG and OCT4. Yellow dashed insets show cells at high magnification and5
white dashed lines mark SOX17 +ve and/or BLIMP1 -ve cells. Scale bar: 20 µm.6
c. PS (~E12) stage embryo with a cluster of pPGCs (arrow) with multiple7
combinations of PGC gene expression (SOX17, BLIMP1, NANOG, TFAP2C,8
OCT-4, Sda/GM2 and mesoderm gene, T). Arrowheads at the anterior streak9
point to primitive endoderm (SOX17/BLIMP1+ve and NANOG negative cells.10
Scale bar: 20 μm. 11
d. Late-PS; (~E12.5-E13.5) embryo with a pPGC cluster (arrow) showing12
NANOG, SOX17 (split color image of Fig.1e), BLIMP1, and T expression.13
Arrowheads mark early migratory PGCs in the primitive endoderm. Scale bar: 2514
µm.15
e. E14 embryo stained for SOX17, BLIMP1, and TFAP2C. Yellow dashed insets16
show cells at high magnification and white dashed lines mark SOX17/BLIMP117
+ve and TFAP2C -ve cells. Scale bar: 20 µm.18
f. Immunostaining for PRDM14 co stained with Sda/GM2 and SOX17 in E1419
(pPGC cluster) embryos and E26 gonads. Arrows point to pPGCs in the gonad.20
Scale bar: Scale bar: 20 µm.21
22
23
Extended Data Fig.2 Proliferation and development of early pPGCs.24
16
a. OCT4 RNA in situ hybridization identifies the pPGC cluster (arrow) in the1
posterior end of ~E13.5-E15.5 embryos. Insets show whole embryos.2
b. Wholemount OCT4 IHC of a porcine embryo. Dashed square marks the area3
shown at higher magnification on the top right. Arrow points to the pPGC cluster.4
Bottom right: Cross section of the embryo (line in the wholemount image) shows5
migratory pPGCs (red cells).6
c. Number of pPGCs at different stages as indicated.7
d. Immunostaining of EdU labelled embryos at the indicated stages with different8
antibody combinations identifying the PGCs. The pPGC cluster is highlighted9
with dashed white line. Arrows show SOX17/EdU +ve and SOX17/BLIMP1/EdU10
+ve cells. Scale Bar: 20 μm.11
e. Immunostained migratory pPGCs (arrows); inset show cells at higher12
magnification.13
f. Immunostained gonadal pPGCs.14
15
16
Extended Data Fig.3 Epigenetic reprogramming in pre- and early migratory17
pPGCs, and key germ cell markers in migratory pPGC and cultured porcine18
epiblast.19
a. A cluster of pPGCs (dashed line) at ~E13 stained for TET1 and OCT4. Scale20
bar: 20 µm.21
b. Serial sections of E14 embryos immunostained for different epigenetic22
markers combined with BLIMP1, NANOG and SOX17. Dashed lines highlight23
pPGC clusters. Scale bar: 20 µm.24
17
c. Quantification of 5mC and H3M9me2 in embryos of different stages. Numbers1
of cells analyzed are indicated. (* p<0.01; Mann-Whitney test) ).2
d. Serial sections of ~E16 embryos showing migratory pPGCs immunostained3
for the indicated epigenetic marks. Scale bar: 20 µm.4
e. Triple immunostaining of epiblasts cultured under different conditions. Scale5
bar: 10 μm. 6
7
8
Extended Data Fig.4 Characterization of NANOS3-tdTomato (NT) reporter9
hPSC10
a. Targeting strategy for making NANOS3-tdTomato reporter.11
b. Representative genotyping of targeted clones using genomic DNA.12
c. Conventional (Conv) and PGC-competent (Comp) hPSCs states are13
reversible; the latter is equivalent to Pre-ME (12h at ME induction). Conv-hPSCs14
are cultured in Essential 8 medium on vitronectin coated dishes (see Methods).15
Comp-hPSCs are cultured in the hPSC medium containing inhibitor(i)s (GSK3i,16
ERKi, p38i, JNKi) on MEF (see Methods).17
d. NT reporter Conv- and Comp-hPSC, and day 1-4 embryoids induced with or18
without Cytokines.19
e. FACS pattern and % NT/AP +ve cells shown in Extended Data Fig. 4d.20
f. FACS pattern and % NT/AP +ve cells in multiple clones derived from Wis2 or21
H9 hESC lines.22
g. Immunostaining of day 4 embryoids induced from Pre-ME(12h) or23
Comp-hPSC by BMP containing cytokines. Scale bar: 50 µm.24
18
h. Comparison of sensitivity of 2 NANOS3 reporter cell lines. FACS patterns of1
day 4 embryoids induced from Comp-hPSC (harboring NANOS3-mCherry2
reporter or NANOS3-tdTomato reporter) with or without Cytokines.3
i. Comparison of hPGC induction efficiency derived from Pre-ME(12h) or4
Comp-hPSC. Representative images and FACS patterns are shown.5
j. Scatter plot shows % NT/AP +ve cells in indicated condition (n=6). Paired6
T-test was used to test for statistical significance (* p<0.05)7
8
9
Extended Data Fig.5 Characterization of Pre-ME and ME induced from10
Conv-hPSC11
a. Immunostaining of Conv-hPSCs during 12–24h ME induction. Scale bar: 5012
μm.13
b. Gene expression (RT-qPCR) change during ME induction.14
c. FACS patterns of day 4 embryoids induced from Pre-ME(12h) with cytokines.15
Pre-ME was induced with or without GSK3i or Activin A.16
d. FACS patterns of day 4 embryoids induced from Pre-ME(12h) with cytokines.17
Pre-ME was induced with or without BMP2 or the inhibitor.18
e. Schematics of DE or lateral mesoderm (LM) differentiation from ME19
f. FACS patterns of day 2 DE (% CXCR4 +ve) and day 1 LM (% PDGFRa +ve)20
induced from 24h of ME induction.21
g. Relative induction efficiency of DE or LM from ME induced with or without22
BMP2 (DE: n=5, LM: n=6). Paired T-test was used to test for statistical23
significance (* p<0.05)24
h. Immunostaining of DE and LM in Extended Data Fig.5f. Scale bar: 50 µm.25
19
i. Schematic of spatial-temporal progression from Conv-hPSC to ME and the1
signaling.2
3
4
Extended Data Fig.6 Robust induction of cynomolgus monkey PGC5
(cmPGC) from cells during ME differentiation6
a. Schematics of in vitro differentiation of cmPSC. The same system was7
adopted as shown for Conv-hPSC differentiation in Fig.3.8
b. Bright field Image of undifferentiated cmPSC.9
c. Immunostaining of day 2 embryoids induced with Cytokines from cells at 0h10
(=cmPSC), 12h and 24h during ME differentiation. Dashed lines highlight11
SOX17/BLIMP1/TFAP2C +ve cmPGCs. Scale bar: 50 µm.12
d. Immunostaining of day 2 Pre-ME(12h)-derived embryoids in Extended Data13
Fig. 6c for pluripotency markers. Notably, cmPGCs express SOX17 but not14
SOX2. In contrast, cmPSC colonies express SOX2 but not SOX17.15
e. Immunostaining of day 2 cmDE induced from Pre-ME(12h) and ME(24h).16
Scale bar: 50 µm.17
f. Immunostaining of day1 cmLM induced from ME(24h). ME were induced with18
or without BMP. Notably, adding BMP during ME differentiation increased the19
efficiency for FOXF1/HAND1 +ve LM cells, as shown in Conv-hPSC (Extended20
Data Fig. 5e-i)21
Scale bar: 50 µm.22
23
24
20
Extended Data Fig.7 Chronology of transcription factors expression1
during hPGC induction2
a. Schematic of hPGC induction from Pre-ME(12h).3
b. Images of day 2 and 4 embryoids in response to BMP2 alone or BMP2 with4
LIF, SCF and EGF(=Cytokines). Notably, BMP2 alone can induce hPGC at5
almost the same efficiency as the full cytokines, but do not survive during6
extended culture, as shown previously.7
c. Immunostaining of embryoids induced with BMP2 alone or BMP2 with LIF,8
SCF and EGF showing expression of SOX17, BLIMP1 and TFAP2C. Scale bar:9
50 µm.10
d. Proportion of SOX17 +ve cells indicated in Extended Data Fig.7c.11
e. Immunostaining of embryoids induced with BMP2 alone or BMP2 with LIF,12
SCF and EGF showing expression of SOX17, BLIMP1 and NANOG. Scale bar:13
50 µm.14
f. Proportion of SOX17+ve cells in Extended Data Fig.7e.15
16
17
Extended Data Fig.8 Effect of NANOG on hPGC induction, characterization18
of NANOS3-tdTomato reporter hPSC containing inducible SOX17, BLIMP119
with or without TFAP2C, and similarity between Cytokine- and20
SOX17/BLIMP1-induced hPGC21
a. Represents overexpression of Dex-inducible NANOG transgenes in NT22
reporter Comp-hPSC.23
21
b. Day4 embryoids following induction of NANOG (by Dex), with or without1
cytokines as indicated.2
c. FACS patterns after induction of hPGCs; NT/AP +ve cells (%) shown in3
Extended Data Fig. 8b.4
d. Represents overexpression of Dex-inducible SOX17, Dox-inducible BLIMP1,5
Shield1(S1)-inducible TFAP2C transgenes in NT reporter Comp-hPSC.6
e. Immunostaining of NT reporter Comp-hPSC +iSBT 1 day after induction of7
SOX17, BLIMP1 and TFAP2C by addition of Dex, Dox or S1. Scale bar: 50 µm.8
f. Immunostaining of NT reporter Comp-hPSC +iSB 1 day after induction of9
SOX17 or BLIMP1 by addition of Dex or Dox. Scale bar: 50 µm.10
g. Immunostaining of day 2 embyroid induced with or without Dex to induce11
nuclear localization of SOX17. Notably, accumulation of SOX17 signal is12
observed in +Dex condition.13
h. Changes in gene expression (RT-qPCR) during hPGC induction:14
Comp-hPSCs control (AP +ve cells); NT +ve hPGCs induced by SOX17/BLIMP115
or Cytokines; NT -ve cells in cells exposed to Cytokines.16
i. Unsupervised hierarchical clustering (UHC) of gene expression.17
j. Gene set enrichment analysis (GSEA) of 123 hPGC-specific genes18
(Supplementary Table 1) on the transcriptome of cytokine- and19
SOX17/BLIMP1-induced hPGCs.20
k. Heat map showing expression of epigenetic modifiers related to global DNA21
demethylation. Same datasets as shown in Fig. 4e were used for analysis.22
23
24
22
Extended Data Fig.9 Response of SOX17 KO Comp-hPSC to SOX171
a. Overexpression of Dex-inducible SOX17 (iS) in SOX17 KO Comp-hPSC.2
b. Gene expression (RT-qPCR) on day 4 of FACS-sorted NANOS3-mCherry3
(NC)/Alkaline phosphatase (AP) +ve hPGCs by RT-qPCR.4
c. FACS analysis of d2 embryoids induced from WT Comp-hPSC, SOX17 KO5
Comp-hPSC and SOX17KO Comp-hPSC rescued with SOX17GR transgene6
(iS) (% CXCR4/AP+ cells).7
d. FACS pattern of day 2 embyoid induced from NT reporter Comp-hPSC8
showing AP/CXCR4 +ve cells expressing NT.9
e. Represents SOX17 inducible system (iSdd). Expression of SOX17 fused with10
destabilized domain (DD) can be induced by Doxycycline (Dox); addition of11
Shield1 (S1) can stabilize SOX17-DD protein.12
f. Western blots showing SOX17 expression level in day 5 embryoids from13
SOX17KO+iSdd Comp-hPSC. Embryoids were induced with Cytokines. To14
induce SOX17, different concentration of Dox and S1 were added. As controls,15
NC/AP +ve hPGCs and NC/AP -ve cells from WT Comp-hPSC-derived16
embryoids induced with Cytokines were used. Histone H3 (H3) was used for17
internal control.18
g. Immunostaining of day 4 embryoids from SOX17KO+iSdd Comp-hPSC.19
Embryoids from SOX17 KO and WT Comp-hPSC induced with Cytokines were20
used as controls. Scale bar: 50 μm.21
h. Quantification of immunostaining data in Extended Data Fig. 9g. The22
numbers of OCT4/BLIMP1 +ve hPGCs, FOXA2 +ve endodermal cells and23
23
OCT4/BLIMP1 +ve hPGCs expressing FOXA2 were counted from 3 different1
embryoids. The proportions of the 3 populations are shown.2
i. Expression of SOX17 and BLIMP1 (RT-qPCR) in d4 embyoids in response to3
different SOX17 dosage.4
5
6
Extended Data Fig.10 Response of SOX17 KO Comp-hPSC to SOX17 and7
BLIMP1, and changes in epigenetic modifier expression after8
overexpression of SOX17/BLIMP19
a. Overexpression of Dex-inducible SOX17 (iS) and Dox-inducible BLIMP1 (iB)10
in SOX17 KO Comp-hPSC.11
b. Immunostaining of Comp-hPSC 1 day after induction of SOX17 (Dex) or12
BLIMP1 (Dox), or both, and d2 embryoids following Dex-induced SOX17 with13
endogenous or Dox-induced BLIMP1. Scale bar: 50 μm. 14
c. Gene expression (RT-qPCR) in day 4 embryoids following induction by Dex15
(+SOX17), Dox (+BLIMP1), or Dex+Dox (+SOX17/BLIMP1). Bulk cells of16
embryoids induced from SOX17 KO and WT Comp-hPSC with Cytokines were17
used as controls.18
d. Upon specification, hPGCs become refractory to Activin or Wnt signaling. Left19
schematic shows the experimental design. The embryoids were transferred to20
the medium with or without GSK3i (3M) or ActivinA (100ng/ml) at day 0, 1 or 221
to see the effect on PGC induction. FACS patterns (right) show the induction22
efficiency of hPGC (%; NT/AP +ve) at day 4.23
e. Day4 embryoids induced by cytokines with or without ActivinA or GSK3i.24
24
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Methods1
Porcine embryo collection2
All the procedures involving animals have been approved by the School of3
Biosciences Ethics Review Committee, The University of Nottingham. Embryos4
were collected from crossbred Large White and Landrace sows (2-3 years old)5
between days 10 and 16 after artificial insemination (AI). Embryos from days6
10-16 (embryonic day (E) 10-16; (bilaminar (n=4); Pre-PS (n=7), Early-PS (n=6);7
PS (n=10), Late-PS (n=13), ~E14 (n=8), ~E16 (n=10)) were flushed from the8
uterine horns with 30-40 ml warm PBS (supplemented with 1% FCS). Embryos9
older than E15 were retrieved by cutting the uterus longitudinally from the10
antimesometrial side and picked with forceps. Embryos at each stage were11
retrieved from multiple sows. All embryos were grouped by stages and washed12
with DMEM-F12 (Thermo Fisher Scientific) + 20% knockout serum replacement13
(KSR: Thermo Fisher Scientific) supplemented with 25 mM HEPES (wash14
medium, WM) and transported to the laboratory in a portable incubator at15
38.5°C.16
17
18
Immunohistochemistry of porcine embryos and gonads19
Embryos were processed as previously described31. Briefly, embryos and20
gonads were fixed in 2.5% paraformaldehyde (PFA) in PBS overnight (ON) at21
4ºC and transferred to methanol at -20°C for long term storage. For less22
advanced embryos (E9.5-10.5) 2% agarose blocks were made before23
embedding in wax. Agarose blocks were then trimmed and dehydrated with24
29
increasing concentrations of ethanol (70%, 90% and 100%) for 2 h each step.1
After dehydration, blocks were processed in xylene followed by hot paraffin wax2
for 2 h and then cooled down in a metal mold. E14-15 embryos and gonads were3
dehydrated, embedded and processed as described above. All paraffin blocks4
were cut into 4 µm thick sections and mounted onto SuperFrost plus slides.5
Sections were air dried ON and immunohistochemistry was conducted6
subsequently. For cryo-sections, fixed embryos were incubated in 30%7
sucrose/PBS ON at 4ºC prior to mounting in OCT compound. Cryo-sections8
were cut at 6 µm onto Superfrost plus glass slides. Sections were left to air dry9
for 1-2 h before IF. Unused slides were kept at -80°C in air tight containers.10
11
12
Immunofluorescence staining of porcine embryos13
Sections were dewaxed with xylene for 30 min and rehydrated with decreasing14
concentrations of ethanol (100%, 90% and 70%) and transferred to PBS for 1515
min. Antigen retrieval was then performed by boiling the slides in 0.01M Citrate16
Buffer (PH 6.0) for 10 min. Sections were permeabilized with 1% Triton-X100 in17
PBS for 15 min. Triton-X100 was washed three times for 5 min each, and18
blocking solution (PBS supplemented with 5% BSA or 10% Donkey serum/5%19
BSA/PBS) was added for 1-1.5 h. After blocking, sections were incubated with20
the desired primary antibody (see Supplementary Table 2) ON at 4°C in a21
humidified chamber. Slides were then washed three times with 0.1%22
Tween-20/PBS. Finally slides were incubated with fluorescent (TRITC, Cy323
Alexa Fluorophore 488, 555, 568 and/or 647; eBioscience, Abcam, Thermo24
30
Fisher Scientific)-conjugated secondary antibodies for 40 min at room1
temperature (RT). Slides were mounted with Fluoroshield with DAPI (Sigma)2
and sealed with nail varnish. Slides were kept at -20 °C until observed.3
4
5
Porcine epiblast cultures and quantification of PGC induction6
Embryos collected 11.5 days post AI were dissected under a dissecting7
microscope as described previously32. Trophectoderm and primitive endoderm8
were carefully removed with forceps and pure epiblasts were placed in9
pre-incubated in GK15 medium supplemented with individual inhibitors (i),10
including 10 µM WNTi (IWR-1-endo, Selleckchem), and 100 nM BMPi11
(LDN193189, Sigma,). GK15 medium is composed of GMEM (Thermo Fisher12
Scientific) supplemented with 15% KSR, 0.1 mM 2-mercaptoethanol (Thermo13
Fisher Scientific), 0.1 mM NEAA (Thermo Fisher Scientific), 1 mM sodium14
pyruvate (Sigma), 100 U/ml Penicillin- 0.1 mg/ml Streptomycin (Sigma), and 215
mM L-Glutamine (Sigma). After 30 min incubation with the inhibitors, cytokines16
were supplemented to the final concentration of 500 ng/ml BMP4 (R&D17
systems), 1mg/ml hLIF (Peprotech) and 200 ng/ml SCF (R&D systems).18
Epiblasts collected from two independent batches of animals and from 4 animals19
each time were grouped by stage of development (bilaminar, Pre-PS, Early-PS)20
and randomly distributed into three treatment groups. After 64 h incubation in a21
low oxygen incubator at 38.5ºC they were fixed in 2.5% PFA at 4ºC ON. After22
washing in PBS they were incubated in 30% sucrose/0.0025% sodium azide at23
4ºC ON and then mounted in OCT compound as described above. IF was24
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carried out with the antibodies listed in Supplementary Table 2 with1
fluorescent-conjugated secondary antibodies.2
All immunostained sections of single epiblasts were imaged at 100x3
magnification at antibody-specific wavelengths. NANOG-positive cells could be4
split into two categories; high expression and lower expression, based on5
immunofluorescence intensity. Image acquisition was performed using6
SimplePCI capture software and the Cell Counter application of Fiji was used to7
mark protein of interest and NANOG-high cells. Separate fluorophore images8
were overlaid and cells marked as positive for all three proteins of interest were9
counted. Only robustly stained cells were considered positive. No statistical10
methods were used to predetermine sample size. Mann-Whitney test was used11
to test for significance.12
13
14
Wholemount In situ hybridization15
RNA in situ hybridization (ISH) was carried out as previously described15. Briefly,16
embryos (NP (n=2); 3-5S (n=3); 6-8S (n=3)) were rehydrated in decreasing17
concentrations of methanol and then washed in PBS-T (PBS + 0.1% Tween-20).18
Next, embryos were equilibrated in (1:1) PBST:Hybridisation buffer (HB:19
Formamide: 50%, 2xSSC (pH5), EDTA (5mM, pH8), 0.05 mg/ml Yeast RNA,20
0.2% Tween20, 0.5% CHAPS, 0.1 mg/ml Heparin) for at least 10 min, and then21
transferred to HB before incubating at hybridisation temperature (HT) for a22
minimum of 2 h. After incubation, HB containing pig OCT4 probe was added and23
incubated ON. The following day the probe was removed and embryos were24
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washed 3-5 times with wash buffer (WB: 50% Formamide, 1xSSC (pH5), 0.1%1
Tween20) at HT, and then equilibrated with (1:1) WB:MABT solution (MABT2
solution: 100 mM Maleic acid, 150 mM NaCl, 0.005% Tween 20) before3
washing with MABT solution at RT. The embryos were then blocked with MABT4
and of 2% blocking reagent (Roche) for 1 h followed by blocking solution with5
MABT, 2% blocking reagent and 10% normal goat serum for at least 2 h. The6
blocking solution was then replaced with a 1:2000 dilution of anti-Dig-AP Fab7
fragments (Roche) and incubated overnight with gentle agitation at 4ºC.8
Embryos were rinsed in MABT several times before the development step with9
NBT/BCIP. After color reaction embryos were washed with 5xTBST (TBST: 0.710
M NaCl, 0.01 M KCl, 0.125 M Tris (pH7.5), 0.5% Tween20) solution. The colour11
reaction was repeated until signal was detected. Once the colour reaction was12
satisfactory, the embryos were re-fixed with 4% PFA for 1 h, rinsed in PBST and13
observed under a microscope.14
15
16
EdU labelling17
Embryos collected (n=7) were rinsed in WM before 6 h incubation in 10 uM EdU18
at 38.5ºC. After rinsing the embryos were fixed in 4% PFA for 2 h and then19
transferred to 1% PFA for long term storage. Embryos were processed for20
immunohistochemistry as described above, except that the EdU staining21
protocol was performed following manufacturer instruction (Click-iT EdU,22
Invitrogen) prior to addition of primary antibodies used for co-labelling.23
24
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1
Cell culture2
NANOS3-mCherry hPSC, SOX17KO hPSC, SOX17KO+iS hPSC lines were3
established previously4. NANOS3-tdTomato hPSC line was newly generated by4
gene targeting (See Vector construction and gene Introduction). A5
cynomolgus monkey PSC (cmPSC) line (MF12 embryonic stem cells (ESCs)) is6
kindly gifted from E. Curnow, Washington National Primate Research Centre.7
Undifferentiated Conv-hPSC were maintained on vitronectin (Thermo Fisher8
Scientific)-coated plate in Essential 8 medium33 (Thermo Fisher Scientific)9
according to manufacturer’s protocol. Cells were passed every 3-5 days using10
0.5 mM EDTA/PBS without breaking cell clumps.11
Undifferentiated Comp-hPSC were maintained on Mitomycin-C treated or12
irradiated mouse embryonic fibroblast (MEF) (purchased from MTI-GlobalStem13
or prepared in house) in knockout DMEM (Thermo Fisher Scientific)14
supplemented with 20% KSR, 0.1 mM NEAA, 0.1 mM 2-mercaptoethanol, 10015
U/ml Penicillin- 0.1 mg/ml Streptomycin, 2 mM L-Glutamine, 20 ng/ml human LIF16
(Stem Cell Institute, university of Cambridge (SCI)), 8 ng/ml bFGF (SCI), 1 ng/ml17
TGF1 (Peprotech), 3 M GSK3i (CHIR99021,Miltenyi Biotec), 1 M ERKi18
(PD0325901,Miltenyi Biotec), 5 M p38i (SB203580,TOCRIS bioscience), and 519
M JNKi (SP600125, TOCRIS bioscience), as reported4,34. Cells were passed20
every 2-4 days using TrypLE express or 0.25% trypsin/EDTA (Thermo Fisher21
Scientific). Before harvesting Comp-PSC on MEF, 10 M of ROCKi (Y-27632,22
TOCRIS bioscience) was added into the medium.23
34
Undifferentiated cmPSC were maintained on Mitomycin-C treated or irradiated1
MEF in DMEM/F-12 (Thermo Fisher Scientific) supplemented with 20% KSR,2
0.1 mM NEAA, 0.1 mM 2-mercaptoethanol, 100 U/ml Penicillin- 0.1 mg/ml3
Streptomycin, 2 mM L-Glutamine, 20 ng/ml bFGF (SCI). Before differentiation,4
cmPSC were maintained on MEF in Essential 8 medium supplemented with 5%5
KSR, 2.5 M WNTi (IWR-1; Tocris) at least for 2 passage. Cells were passed6
every 3-4 days using 0.25% trypsin/EDTA (Thermo Fisher Scientific). Before7
harvesting cmPSC on MEF, 10 M of ROCKi (Y-27632, TOCRIS bioscience)8
was added into the medium.9
For ME induction and subsequent DE/LM induction, we optimized published10
protocol18,35,36 with slight modification. For the basal medium, we used aRB2711
medium which is composed of Advanced RPMI 1640 Medium (Thermo Fisher12
Scientific) supplemented with 1% B27 supplement (Thermo Fisher Scientific),13
0.1 mM NEAA, 100 U/ml Penicillin- 0.1 mg/ml Streptomycin, 2 mM L-Glutamine.14
For ME induction, trypsinized Conv-hPSC were seeded on vitronectin-coated15
dish at 200,000 cells/well in 12 well plate and cultured in ME induction medium16
for 6-36 h as indicated in the figures. ME induction medium was composed of17
aRB27 medium supplemental with 100 ng/ml Activin-A (SCI), 3 M GSK3i and18
10 M of ROCKi. For DE induction, ME induction medium was replaced to DE19
induction medium after washing with PBS once and cells were cultured for20
further 2-3 days. DE induction medium was composed of aRB27 medium21
supplemented with 100 ng/ml Activin-A and 0.5 M BMPi (sigma). For LM22
induction, ME induction medium was replaced to LM induction medium after23
washing with PBS once and cells were cultured for further 1 day. LM induction24
35
medium was composed of aRB27 medium supplemented with 100 ng/ml BMP21
(SCI), 2.5 M WNTi (IWR-1) and 10 M TGFi (SB 431542; Tocris) .2
Embryoids were formed according to previous report4. Briefly, Conv- or3
Comp-hPSCs, Pre-ME or ME were trypsinized into single cells and harvested4
into Corning® Costar® Ultra-Low attachment multiwell 96 well plate (Sigma) or5
PrimeSurface 96V plate (S-BIO) at 4000 cells/well in GK15 medium or aRB276
medium. To improve the cell aggregation, in some experiments, we added7
0.25% (v/v) poly-vinyl alcohol (sigma) in the basal medium, according to8
published protocol37. For hPGC induction with Cytokines, 500 ng/ml BMP4 or9
BMP2 (SCI), 10 ng/ml human LIF (SCI), 100 ng/ml SCF, 50 ng/ml EGF (R&D10
Systems), and 10 M ROCKi were added to GK15 medium or aRB27 medium.11
Notably, an use of aRB27 medium for the basal medium improved the efficiency12
of hPGC induction, especially, when we used the Pre-ME cells (see Extended13
Data Fig. 4i,j).14
For induction of exogenous transgenes, 100 uM Dexamethasone (Sigma), 0.515
ug/ml Doxycycline (Sigma) and/or 0.5 uM Shiled-1 (Clontech) were added to the16
medium.17
18
19
Vector construction and gene introduction20
For construction of NANOS3-tdTomato knock-in targeting vector, 5’ and 3’ arms21
amplified from NANOS3-mCherry knock-in targeting vector4,22
rox-PGK-Purotk-rox amplified from pL1L2-PGKpurotk (a kind gift from SCI),23
MC1-promoter driven DTA cassette amplified from pMC1-DTA, were cloned into24
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pBluescript KS(+) (Stratagene) with an in-fusion HD cloning kit (Takara Bio). For1
efficient gene targeting, we used the CRISPR/Cas9 system. Guide RNAs2
targeting around the stop codon sequence of NANOS3 genes3
(5’-caccgAGCCTCCTAGGTGGACATGG-3’, 5’-4
aaacCCATGTCCACCTAGGAGGCTc-3’) were cloned into pX330 (Addgene) or5
eSpCas9(1.1) (Addgene). For construction of pCAG-Dre-IRES-Hygromycin,6
puromycin resistance gene in pCAGGS-Dre-IRES-Puro was replaced to7
hygromycin resistance gene. For construction of Dox/Shiled-1 inducible system,8
SOX17 cDNA without stop codon amplified from cDNA of hPGC and9
Destabilized-domain amplified from pBMN YFP-FKBP (Addgene) were cloned10
into PiggyBAC vector used previously38. For construction of Dox-inducible11
system, Tet3G amplified from pCMV-Tet3G (Clonetech) was cloned into12
PiggyBAC vector which contains CAG-promoter and IRES- neomycin-resistance13
gene. TRE3G cassette amplified from pTRE3G (Clonetech), human BLIMP114
cDNA amplified from TRE-Tight BLIMP1-EGFP38 ,human NANOG cDNA15
amplified from pEP4-E02S-CK2M-EN2L (Addgene) and human TFAP2C16
cDNA amplified from hPGC were cloned into PiggyBAC vector. All fragments17
were amplified by PCR using PrimeSTAR MAX or PrimeSTAR GXL DNA18
polymerase (Takara Bio) according to the manufacturer's protocol.19
For gene targeting of NANOS3-tdTomato reporter, WIS2 male hESC and H920
female hESC lines were used. For the gene targeting method, electroporation or21
lipofection was carried out as described before4. In brief, for electroporation, 1~522
x 10e6 Comp-hPSCs suspended in PBS were mixed with targeting vector and23
CRISPR/Cas9 plasmid was transferred to a Gene Pulser cuvette (Bio-Rad).24
37
Electroporation was carried out using Gene Pulser equipment (Bio-Rad). For1
lipofection, reverse transfection was carried out. 2 x 10e5 Comp-hPSCs were2
suspended in 100-200 l of Opti-MEM containing targeting vector,3
CRISPR/Cas9 plasmid and lipofectamine 2000 (Thermo scientific) complex, and4
left them for 5 min at room temperature. After electroporation or lipofection,5
PSCs were seeded onto 4 drug resistant (DR4) MEF (GlobalStem or SCI) and6
48 h later, 0.5ug/ml puromycine (Sigma) was added to the culture medium for7
selection. After the selection, puromycin resistant hPSC colonies were picked up8
and judged correct targeting by PCR using following primers (Primer F1;9
5’-GGGGCCAGTCTAACTAGGTGTG-3’, Primer R1;10
5’-GGTCTTCCTGGAAATCCAGCCG-3’, Primer R2; 5’-11
TGCCGGTGCCATGCCCCAGGAACA-3’ see Extended Data Fig. 4a, b). The12
targeted clones were expanded and then used for excision of Rox-flanked13
PGK-Purotk by transient transfection of pCAG-Dre-IH. After selection with 2514
ug/ml hygromycin B and subsequently with 0.2 uM FIAU, colonies were picked15
up and judged the excision by adding puromycin or PCR using following primers16
(Primer F2; 5’-CCGTCCCATGCACGTCTTTATC-3’, Primer F3;17
5’-GAGGGCAGAGGAAGTCTGCTAACA-3’, Primer R3; 5’-18
GGTCTTCCTGGAAATCCAGCCG-3’ see Extended Data Fig. 4a, b). In the19
representative clone derived from Wis2 hESC used in this study, G-banding20
karyotype analysis was performed at Medical Genetics Laboratories, Cambridge21
University Hospitals NHS Foundation Trust following their standard protocols,22
and the normal karyotypes were confirmed (20 out of 20 cells).. All clones23
showed correlation of NANOS3-tdTomato and TNAP expression by FACS24
38
analysis (representatives are shown in Exteneded Data Fig. 4d-f). We also1
confirmed NANOS3-tdTomato +ve cells are specifically expressing the other2
PGC markers by immunostaining (Exteneded Data Fig. 4g). Notably,3
fluorescence of NANOS-tdTomato was brighter than NANOS3-mCherry which4
we made in previous report4 (Exteneded Data Fig. 4h).5
For gene introduction using PiggyBAC system, reverse transfection was6
carried out. 2 x 10e5 SOX17 KO Comp-hPSCs, NANOS3-tdTomato7
Comp-hPSCs were suspended in 100-200 l of Opti-MEM containing plasmids8
and lipofectamine 2000 (Thermo scientific) complex, and left them for 5 min at9
room temperature. The cells were seeded on DR4 MEF at several different10
concentrations, and then 48 h later, drugs for selection were added to the culture11
medium.12
13
14
Quantitative reverse transcription PCR (RT-qPCR)15
Total RNA was extracted using PicoPure® RNA Isolation Kit (Thermo Fisher16
Scientific) and cDNA was synthesized using QuantiTect Reverse Transcription17
Kit (QIAGEN) according to manufacturer’s protocols. RT-qPCR were performed18
and analyzed as described previously39 and the primers sequences used in the19
paper are listed in Supplementary Table 3. Values normalized to GAPDH and20
relative to control samples (Comp-hPSC or hPGC) are shown in the figures.21
Error bars are mean ± SD from technical triplicate with two experiments.22
23
24
39
Immunofluorescence staining of cells and cryo-section of embryoids1
Cells were cultured on -Slide 8 well (ibidi) and fixed in 4% PFA for 10 min at2
room temperature. Embroids were fixed in 4% PFA for 2-4 h or ON at 4℃ and3
embedded in OCT compound for frozen sections. Each sample was incubated4
with primary antibodies for 1-2 h at RT or ON at cold room and with5
fluorescent-conjugated secondary antibodies for 1 h at RT. Antibodies used6
here are listed on Supplementary Table 2. After antibody treatment, samples7
were stained with DAPI (Sigma) to mark nuclei and were observed under8
confocal laser scanning microscopy.9
10
11
Flow cytometry analysis12
PSCs, Embryoids, DE and LM were trypsinized with 0.25% trypsin/EDTA at 3713
℃ for 5-15 min and were stained with Alexa-488 or 647 conjugated anti-TNAP14
antibody (BD Bioscience), PerCP-Cy5.5 conjugated anti-CXCR4 antibody15
(Biolegend), PE-Cy7 conjugated anti-PDGFRa antibody (Biolegend) and/or16
Alexa-647 conjugated anti-CD38 antibody and subjected to FACS LSR Frotessa17
cytometry (BD Bioscience). FACS data were analyzed by Flowjo software.18
19
20
Western blot analysis21
Western blot analysis was carried out as described before4. Briefly, whole-cell22
extracts were prepared by day 4 embryoids in lysis buffer composed of 50mM23
Tris-HCl (pH7.5), 0.15M NaCl, 0.1% SDS, 1% Triton X-100, 1% Sodium24
40
deoxycholate and cOmplete mini EDTA free (Roche Applied Science,1
Penzberg, Germany). After electrophoresis, proteins were transferred to2
nitrocellulose membranes. Membranes were incubated in Western Blocking3
Reagent (Roche Applied Science) and treated with antibodies. Primary4
antibodies against SOX17 (goat IgG; R&D systems, see Supplementary Table5
2), and H3 (rabbit IgG; Abcam ab1791) were used. Horseradish6
peroxidase-conjugated secondary antibodies against goat or mouse IgG were7
added (Dako, Life technologies). After antibody treatment, blots were developed8
using ECL Western Blotting Detection System (GE Healthcare).9
10
11
Preparation of RNA-sequencing (RNA-seq) libraries12
Total RNA (5 ng) was reverse transcribed and amplified into cDNA using13
Ovation RNA-Seq System V2 (Nugen). Amplified cDNA was sonicated into 25014
bp by Covaris S220 Focused-ultrasonicators. Subsequently, RNASeq library15
was generated with 500 ng of fragmented cDNA using Ovation Rapid DR16
Multiplex System (Nugen). Library was quantified by qPCR using KAPA Library17
Quantification Kit (Kapa Biosystems). Libraries were subjected to single-end 5018
bp sequencing on HiSeq 2500 sequencing system (Illumina). Every 4 indexed19
libraries were multiplexed to one lane of a flowcell, resulting in >40 millions20
single end reads per sample21
22
23
Bioinfomatics analysis24
41
Adapter-and quality-trimmed RNA-seq reads were mapped to the human1
reference genomes (UCSC GRCh37/hg19) using TopHat22
(http://ccb.jhu.edu/software/tophat, version: 2.0.13) guided by ENSEMBL 833
gene models. Raw counts per transcripts were obtained using featureCounts,4
only the longest transcript per gene was kept. Replicates were evaluated, raw5
counts were normalized, and the differential expression of transcripts was6
statistically evaluated by the R Bioconductor DESeq2 package7
(www.bioconductor.org). Expression-normalized transcript counts were further8
normalized by transcript length (per kB). Transcript annotations in all9
bioinformatics analyses were based on ENSEMBL (Release 83) considering10
protein coding, long-noncoding RNA and processed transcripts. Hierarchical11
clustering was performed with the R hclust function using the Ward’s method.12
Principal components were computed by singular value decomposition with the13
R princomp functioned on scaled DESeq-normalized expression levels. Only the14
80% most highly expressed transcripts were used for clustering and principal15
component analysis. t-statistic Stochastic Neighbor Embedding (t-SNE) analysis16
was performed using R Rtsne package with default parameters and “perplexity =17
3”. Gene set enrichment analysis (GSEA) was performed with the R phenoTest18
package on RNAseq data (log2(normalized counts)). hPGC-specific genes were19
defined as follows: (1) upregulated in week 7 male hPGC over gonadal somatic20
cells (log2(fold change) >3 and adjusted p value <0.05); and (2) upregulated in21
d4 hPGC+Cy over comp-hPSC in our previous study4; and (3) upregulated in22
week 7 male hPGC over comp-hPSC.23
24
42
1
Data availability2
RNA-seq data have been deposited in Gene Expression Omnibus (GEO) under3
accession number GSE85378. All other data are included within the paper,4
source data and Supplementary Information.5
6
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gene.symbol hESC.SB1 hESC.SB1.1 hESC.W15 hESC.W15.1 PGCLC.D1.DD
APOE 8.596018998 8.861014098 8.426161467 8.587979933 9.654842323
MKRN1 8.384838643 8.356207256 8.57620232 8.444875456 9.172017229
PDPN 8.031643387 8.038782256 7.533708895 7.576321854 10.57081358
TCL1A -0.350360289 -0.352897479 0.369251498 -0.334552612 -0.316657072
EPB41L2 9.062313803 9.241597472 9.071371878 9.069468612 8.639237415
PCSK1N 1.644463189 2.056963498 -0.220887524 1.660270866 7.369328311
MYBL2 8.677424622 8.657203513 8.796242211 8.797739259 9.213197332
SCGB3A2 12.34683261 12.57735976 12.58863099 12.63737107 9.609751952
LMO2 3.575531269 3.388569507 3.236249367 3.647922474 4.772733218
RASD1 4.967218281 4.490749902 4.435291301 4.587097281 9.579860211
PIM2 8.336571749 8.498457584 8.387027323 8.384957795 10.3083627
STOM 7.287550506 6.836028484 6.973214961 6.798339316 8.902857212
AKAP12 8.339032348 8.219382613 8.503370115 8.361171432 10.26311107
ETV5 6.003731483 6.273180299 5.843876935 6.178112186 7.974732202
SAMHD1 4.472290737 4.361693801 4.51085292 4.45804118 6.657625172
LCP1 6.059960073 6.144885724 7.436830754 7.798233774 5.1292872
CDCA7 7.8753624 7.758405299 7.431644676 7.557026932 6.209683206
NANOG 10.4631086 10.54675118 10.65125999 10.59386163 9.736796919
KIT 5.256839669 5.426881934 4.585130026 5.076582207 6.790696999
NLRP9 1.498674155 -1.673788037 0.370289035 0.34455683 1.532377372
TRIML2 5.667048587 5.52510834 7.14435741 6.624753309 1.037786792
NANOS3 0.497221812 0.494684621 1.216833599 0.513029489 6.174781219
FAM162B 2.669481649 3.541413577 3.389093437 3.100326826 5.577653985
ASRGL1 7.631795723 7.779153963 7.877866292 7.787976056 8.796285547
HENMT1 4.583365149 3.223275955 4.337742355 2.826583322 3.95995608
UPP1 6.060587233 5.961542061 7.171707984 7.150819751 6.12784301
CACNA2D2 6.094449489 5.873732129 4.736058764 5.118669406 9.895795116
ESRP1 8.788137918 8.888988559 9.042199048 8.99469239 10.44456206
COL4A3BP 6.553955734 6.506094553 6.630176042 6.464906097 9.285579478
PQLC3 4.987368024 4.780472335 5.336611361 4.734686865 5.521969477
ERVW-1 4.70352913 4.528810965 4.671068431 4.351605023 7.369500563
ETV4 6.475193496 6.816388771 7.007381691 7.083268474 7.939412944
SOX15 5.668899383 5.198583231 5.723695362 5.247301747 7.719153776
DNMBP 6.03897138 6.407222435 7.577021589 7.338373328 6.899500804
TFCP2L1 2.912103789 2.464155451 3.538606172 3.015374308 8.011223141
CPEB1 3.163768454 2.161231263 3.919004151 3.665002958 5.852823499
GABRA3 0.237457236 1.55684814 0.542031524 1.060619835 5.369192536
TCL1B 4.042954752 3.983834033 2.762566539 2.817754329 3.546143252
SMAGP 5.162345658 4.319286682 5.754722257 5.101191353 2.629702053
BEND4 5.218997636 5.100983228 5.332993251 4.911670447 4.742944697
SLC43A1 5.926639489 5.246030394 6.470679712 6.156226457 6.266151136
FAM46B 6.512668677 6.546110784 6.515813181 6.088944293 6.97229771
TFAP2C 7.061462623 6.897733168 7.603658897 7.18064804 8.734067148
PLBD1 7.271591457 7.339041785 7.206345926 7.088715139 7.096895525
NFE2L3 7.650413967 7.509521855 7.291313779 7.321776113 7.17984253
OSBPL3 5.592824352 5.500401658 5.498409082 5.265980455 4.907204936
GPHA2 0.554328015 1.551790825 1.273939802 1.570135692 4.909959327
DDIT4L 3.139013154 2.44459826 2.714235032 2.84996625 6.334987801
CABYR 5.558959528 5.185328186 5.053697905 4.929050673 6.720670358
PHLDA3 5.816954472 4.970068153 5.341309968 4.921298824 6.301764444
SCUBE2 0.712787098 -0.512142513 0.794968965 -0.493797646 4.187062907
KIAA0226 4.689626299 4.029976822 4.590844893 4.048321689 4.421059947
KLF4 4.095650814 3.919084224 4.622617523 4.484916886 6.291974232
GCNT1 5.635735718 5.64376777 5.457709223 5.488893058 7.348505003
SUSD2 2.579940161 3.180067474 2.245104165 2.010785338 6.878346605
EFEMP1 3.892113463 3.853952363 3.061528167 3.009800754 3.568264675
CRIP1 2.285480189 1.282942999 1.683163882 3.564322272 7.074070909
PROM1 6.690020092 6.319864899 5.454774035 5.239324101 7.682577326
FAM102B 4.674949152 4.953824897 4.826149615 4.712783135 6.60713361
PCP4L1 1.940783671 1.616318386 2.660395459 3.722126095 5.992408797
FRMD6 4.384891828 4.481890311 4.408657008 4.740185971 5.196202624
UTF1 1.50283178 1.50029459 2.222443567 2.741031878 6.580929117
PRDM1 9.147785589 9.243527917 7.126300299 7.870434785 15.35813953
CLEC4D 1.177161283 0.174624093 0.896773071 2.652400579 5.514645249
TLDC2 2.772395405 2.769858215 2.598922397 2.409691459 4.059855215
ITGB3 2.1329937 3.339909876 2.710586483 2.956156299 5.634302468
IL4R 4.496338018 4.585723317 4.611878482 4.787780137 4.968614249
STON2 6.029064489 5.679114232 5.679689666 5.800798849 5.896346945
RBM24 3.015265249 2.860724965 2.412948941 3.796607672 6.048968466
ATP2A3 2.869657254 2.189048159 2.911197136 2.972927772 7.676499678
PSORS1C2 1.926639489 0.924102299 1.231213777 1.942447166 3.282270801
CAPN13 4.03626398 3.756192814 3.681875186 3.315106063 5.475959557
SOX17 6.274293032 7.031142731 4.885651929 7.023585735 6.681149668
PIFO 4.953047322 5.029222108 5.390623742 5.060278027 4.959529071
KLRG2 4.665939675 4.482830239 4.468013622 3.709761728 3.550779506
NLRP7 5.552387604 6.062663129 5.827336723 6.23301109 6.437992183
GABRQ 4.188161763 3.543518165 3.613590446 3.494748837 8.257318066
TDRD12 1.967425104 1.479461086 2.201610064 1.34580286 2.28123624
GNA14 3.140261701 3.400758916 3.345300315 3.293572901 3.173964918
AFAP1L1 2.069872373 1.526766801 0.959409161 1.407608145 3.74743178
PPARG 1.91876176 1.693832148 0.415981126 1.127214515 4.099306366
FGFR3 5.117300552 4.768767507 5.743802935 5.545491275 8.64191362
DND1 5.469156636 5.531714474 5.356225169 5.077306344 5.387382636
C1orf115 2.879129332 2.522955187 2.660141664 2.619302566 4.656057134
RIPK4 4.05361696 4.764198622 5.9085806 6.496239304 4.857022558
DEPDC7 2.583031328 3.513379942 3.165139592 3.139407387 4.649156023
ADAMTSL3 1.344143218 0.954582905 1.146217166 1.664805477 2.244579905
FAM124B 1.337215616 1.334678426 1.931296521 1.353023293 6.160995764
RTN4RL1 0.59050542 1.073395057 0.795544034 1.284385002 4.346674662
COL23A1 2.847420472 3.166811377 1.704535783 2.863228149 5.478058832
FMN2 0.251442911 1.248905721 0.864139495 2.414091976 3.178230925
FAM155B 3.877047396 3.64318466 3.1271739 2.59739919 3.285146129
MYB 2.503423574 3.867668714 2.975107848 3.593231832 6.508367798
BSPRY 3.151503337 1.901038633 3.832640977 3.241311595 3.39671066
NGEF -1.552309774 0.030115536 0.489230108 -0.536502097 4.61067646
ADCY1 2.959602773 2.631079271 2.695334225 2.87471645 4.844002046
MMP25 3.429666544 3.297846337 2.827350236 3.486116205 5.673936747
CD38 -1.375039922 0.622422888 -0.33350004 0.225730256 -0.341336705
ADTRP 0.0887314 1.893549132 1.393305688 2.804978795 1.444362712
KANK4 0.906980963 0.904443773 -0.051479155 0.507751141 1.400115799
C12orf39 -0.753159349 2.244303461 -0.033547562 1.584576423 4.565946087
KIF5A 2.912881565 3.343303782 2.834127213 3.38812086 5.470146738
S100Z 3.03626398 3.381650093 3.820006105 4.293079757 3.310975297
FILIP1 1.806144197 2.017731812 2.663259508 2.307378701 3.703785864
HS3ST4 1.447239454 3.398898574 2.488779336 0.463047131 0.480942671
ACE -1.146559722 -0.564134411 -0.841985434 0.19117605 3.72003351
BCL6B 3.15755059 3.203923 -1.980818618 0.637305367 5.493144149
TAC3 2.152554977 2.998014693 1.550238669 1.846434559 4.256647522
TSPAN15 3.616666398 2.688129789 2.673313172 2.84397818 3.209797024
STARD8 3.017702385 2.652595115 3.152351672 2.721566056 3.239032606
CLDN7 6.344527157 6.833170321 6.799085371 7.076980443 7.063849088
UMODL1 0.475522761 0.665630649 1.387779626 0.268938017 3.509225978
SSUH2 0.031751324 0.766179728 0.751363111 -0.5374035 2.387382636
DDX53 1.628703362 2.041203671 2.670243244 2.22947354 2.536875698
PKIB 6.237949909 6.246908358 6.606487256 6.447844638 6.732133597
ANKDD1B 0.77243884 1.577256572 2.192490345 2.595601439 3.850536176
KIAA0319 -1.07042522 -1.07296241 -1.350813433 -1.054617543 0.700243591
LAD1 1.176663029 3.048594957 2.311312316 2.307947924 2.947331841
EVX1 2.594892333 1.855389549 2.214968447 4.025737509 -1.278295045
ADAMTS8 0.125401502 0.444792407 0.166941384 -1.858790821 -1.84089528
LOXHD1 1.680459189 2.262884499 1.5375745 0.833770389 3.147121813
PTPRT -1.957621457 -3.545121148 -3.82297217 -1.204848186 3.524542261
AWAT2 -0.955577497 -0.958114687 -0.235965709 -0.93976982 1.885480643
PGCLC.D1.DD.1 PGCLC.D2.DD PGCLC.D2.DD.1 PGCLC.D4.cytokines PGCLC.D4.cytokines.1
9.547795604 9.818609396 10.19795914 9.470248321 9.581202929
9.496313791 9.496349691 9.615043241 10.43865687 10.62234087
10.82341212 10.94030994 11.15614319 11.17572058 11.23647838
-0.29166848 0.767972025 -0.228285591 5.232721673 5.341067035
8.457985297 8.552916505 8.729429332 10.82507664 10.85919293
7.072388808 8.265295844 8.415195064 8.041989498 8.083124443
9.431477226 9.623266492 9.385925744 10.23209702 10.30007285
9.692153786 9.524456047 9.295364263 10.04733383 10.43367747
5.077829729 5.425046824 5.577311733 4.587513383 5.849170482
10.22125769 10.16108323 10.49187874 9.647446028 10.38111163
10.53853232 10.08846233 10.09750457 10.56140157 10.83280613
9.369538935 9.509439011 9.364470743 10.22771598 10.42905461
10.59072972 10.48139107 10.75519494 10.25612929 10.47336812
7.870633144 7.759921246 7.822095583 8.743721075 8.814118337
6.748053327 7.096618718 7.12373561 8.387012507 8.741580671
5.256155405 6.514575774 6.269497612 8.35592871 8.467594431
6.57027483 6.93761879 6.53800548 8.766151375 9.065195694
10.20292676 10.7168642 10.68581755 11.86052021 11.96854973
6.942390064 7.598133627 7.676730006 7.754724533 7.583580689
0.709369057 1.032043968 0.450823852 1.754289838 1.913261273
1.062775383 5.122415888 5.155905616 8.508356695 9.020869899
5.310801123 4.522444721 4.706759351 5.745884734 5.381294214
5.001191953 5.846707652 6.039483861 6.616975037 7.225979394
9.420062795 9.101932415 9.291254165 9.511530039 9.446663005
4.039392456 4.202126454 4.347887843 4.678834566 4.782310889
6.802645246 7.257368644 6.948196677 7.160932109 7.062745705
10.1867575 10.39111904 10.18102551 10.1563767 10.23353665
10.62087597 10.0930558 10.08466232 9.412076265 9.904729802
9.330599499 9.18455404 9.28313191 9.539299693 9.509833259
6.004639906 6.877625771 6.816150496 8.913806945 8.942801593
6.932145941 7.268117674 7.422538971 6.920483193 7.0858524
7.782198205 7.629685473 7.706535406 8.35138185 8.362922921
7.473407704 7.888985196 7.426817751 7.643095564 7.797390513
6.734828177 6.64643449 6.663328242 7.164666468 7.217262894
8.510923637 7.571532719 7.935045296 7.42999505 7.525796935
5.998564251 6.893863328 6.909358893 5.976332261 6.507272474
5.843043505 7.389212551 7.376340222 8.46936164 8.686631716
3.860638461 4.746249566 4.822141737 7.403006355 7.248955249
3.124175928 3.920782027 4.105096657 8.974909466 8.91148848
4.930204717 5.466475101 5.810557618 8.166663337 8.555466251
6.452030917 6.817561307 6.620256172 8.436011764 8.806949972
7.086662109 7.536919748 7.243791495 7.450763367 7.730280465
8.952031673 9.162169266 8.87059801 9.556939599 9.552992163
7.776616896 8.389923771 8.524635549 9.729221877 9.746940134
7.650478047 7.416172869 7.38415549 8.88550592 9.002789019
5.213707354 6.305769337 5.685555089 7.377206256 7.485344177
5.367907326 4.672660329 4.261365214 3.9798687 4.345291013
6.519633058 5.920310481 5.423359282 4.979591338 5.057032888
6.936601732 6.631967852 6.994010721 7.80568117 7.27357164
6.286111051 6.107239469 6.235161265 7.643416154 7.806637062
4.455977081 4.290551031 4.656863495 7.429814764 7.673675097
4.866499534 5.615313535 5.859290456 5.791884881 6.221771246
7.108538933 7.316793934 7.350750931 7.553612976 7.869019752
7.398127575 7.669420207 7.589210813 8.299897286 8.170437539
6.973856888 7.433232934 7.282517712 7.454035472 6.954677768
3.878655486 5.267603616 5.211225008 6.855852181 7.216295386
7.093706266 6.850068733 7.102435081 6.063692493 5.997371616
8.191695941 7.890618587 7.683032217 7.911591534 8.28937905
7.16248426 7.519106503 7.262496071 8.112391926 8.05563467
5.608284723 7.402523808 8.06285837 10.42477407 10.97815476
5.549972981 6.038261417 6.077132025 8.172121557 8.329329306
6.796740051 6.14472605 6.017223901 5.890897759 6.176981113
15.26775567 15.39924718 15.80060459 9.261997333 9.610528746
6.130670856 5.361582788 4.106590904 6.509592564 5.980096923
4.774503686 4.47569022 5.148226696 6.336215465 6.277956184
5.634629005 6.622013421 6.698011894 5.703584718 6.260240086
4.950958503 4.890304775 4.728037208 6.445186685 6.472332909
6.185419557 6.749102567 6.625294902 8.111580537 7.549564035
5.9119003 6.319464108 6.990337535 6.451861122 7.04093393
7.305559594 6.968129146 7.471512217 5.446507262 4.953402001
3.685771016 4.292899316 4.44103161 5.739203297 5.764908201
5.849843291 6.002593201 6.228728006 7.94326259 7.778317377
6.489326871 7.298356685 7.672379991 9.179902339 9.494132437
5.555674364 5.633693398 6.081847884 7.593106166 7.485821694
3.51163776 3.433774742 4.639150987 5.816647382 6.393286573
6.749382436 7.037681767 7.075133513 6.972504617 7.384969691
8.629131323 8.6698421 8.843509486 4.968229189 5.160520698
2.026116913 2.185293091 2.530072394 2.344602767 3.131605425
3.78391601 5.52162842 5.3833518 7.831146952 7.899622701
3.486116186 4.021094701 4.300471528 3.74916965 4.311496779
3.924986149 4.515141371 3.933921255 2.536947523 3.63933543
8.703239364 7.593184871 7.810123892 7.39699037 7.66377954
5.149336822 5.237546479 6.153826022 8.099667752 7.639200255
4.699661404 4.721827203 5.259001788 7.796630333 7.616850308
5.001750394 4.598763941 4.374237338 6.956505046 7.322101587
4.76725402 4.885788214 5.078564422 5.967641749 6.116196569
2.222262782 3.767330114 2.626682589 6.503381784 6.204147861
5.538865379 6.870585429 7.209718169 6.596295155 6.054178032
3.819122231 4.596363005 4.273295073 6.49750403 6.451857746
5.733931306 6.444724591 6.327047175 7.687304886 7.711060975
3.2576673 3.262860021 3.632251878 5.431283801 5.042405909
4.063494753 3.525894427 3.529636812 5.498312552 6.093695138
6.925212667 6.928417226 6.881396497 5.631648718 6.116848386
1.962267633 4.606870638 4.417967945 4.818501349 4.810016039
4.029943991 5.041755971 4.719512044 3.927678695 3.331762628
4.809347692 3.933118534 4.536681378 7.494372527 7.192104954
5.277938573 4.844980596 5.163925212 5.002764417 5.067098979
0.683651887 3.100844397 3.139352199 7.008272527 7.62407613
1.73238571 3.73062567 3.911245817 5.608248233 5.399068557
1.965672772 3.669169467 3.198980663 6.568719869 6.416762208
4.392995302 3.613100479 4.275805945 2.431373236 3.037803649
5.397838128 5.185019215 5.552231956 4.862948896 5.126077563
3.722987012 3.695164675 3.399346778 5.945789518 5.415101074
4.663923312 4.655659752 4.078778572 3.209317068 3.196107529
-1.494068737 2.266011486 2.739239154 4.695902377 4.331311856
3.371563706 3.463625688 3.9527949 4.385896167 4.213246111
4.643663623 4.002864409 2.743572388 4.532465201 4.753497605
3.589758409 5.341276619 5.122626582 8.320599439 8.292128112
3.127870412 2.29442612 1.812741678 3.678802352 3.574739381
3.365900811 3.77346462 3.697772537 5.08067299 5.071699789
6.759047467 7.097404 6.943355139 7.148161526 7.287896743
3.2814485 3.644481148 3.434098727 4.051480288 3.856020989
1.827408727 3.088683093 2.26930324 5.301172807 4.945571069
4.189895512 4.162073176 3.335740561 4.699579166 3.927813264
6.342084689 5.540245058 5.584064882 5.245194105 5.086975364
4.713773698 5.040518273 4.286830961 4.74546732 4.115942861
1.49076693 1.163384311 1.990248934 0.770152964 0.813647182
3.235354838 4.437953297 5.10609265 5.996281595 5.77039368
-1.253306454 -1.193665949 -1.189923564 5.896918481 5.20143076
-1.815906689 -0.171303683 0.247476201 5.135904688 4.854963955
3.172110405 4.564326249 3.434802103 5.720256681 5.106789641
2.908425274 3.067601453 3.910407619 1.574834432 1.926450945
1.688076813 1.747717318 2.973852124 4.602413484 4.972889025
hPGC.wk7_M hPGC.wk7_M.1 hSoma.wk7_M hSoma.wk7_M.1
11.08634287 10.81188784 6.054554613 5.963872316
11.06229777 11.72127587 7.9188998 7.660901354
10.59303579 10.65195556 5.972540029 6.023869642
10.49579933 10.17962593 1.90375308 1.346194352
10.19019862 9.719463991 6.534071694 7.071475911
10.14323371 8.286740229 4.739878812 2.077983425
9.976901413 9.974230781 6.121984397 5.51746219
9.933304172 9.037893115 5.483359339 6.811629592
9.933049425 9.549070053 4.335535567 5.167388531
9.922371862 9.886974854 6.093175298 6.149199749
9.892592391 8.984123407 5.319626541 4.839472317
9.853503657 9.378526745 6.389660781 5.178426802
9.682010116 10.11055416 6.757097615 6.527017002
9.422132232 9.603716543 6.149086536 5.341985639
9.20736815 8.756121002 5.897980733 5.505570475
9.17754222 8.656140698 4.440605847 4.171552213
9.145597969 8.914279989 5.732656127 5.965644034
9.14468277 9.876426476 5.300233325 4.862514367
9.136378156 9.187542845 3.098569992 2.845865846
9.077297978 9.077576788 -1.417137478 2.112766635
8.97312111 8.723646615 -0.326765558 -0.884324285
8.951323278 9.066214426 0.75133518 1.193776453
8.902399995 9.045999646 0.338632517 -0.21892621
8.850905893 8.616374473 4.269003698 4.230318281
8.819890621 8.96353697 4.801854608 5.009830627
8.75415388 8.516837597 1.712664587 2.807182556
8.740845784 8.665764021 5.534336688 5.321518847
8.722248737 8.706283593 2.600729866 2.498850623
8.694579197 8.664763615 5.230524073 5.562289115
8.6860683 8.511426057 3.798963157 4.00039633
8.674597201 8.567420649 4.612994327 5.561971454
8.590549944 8.969622085 3.499572468 3.407677312
8.554610225 8.400091943 3.601084656 3.249976806
8.547819683 8.469291241 5.358343388 5.321724235
8.532496263 8.657371655 0.253679999 0.068090049
8.476113711 8.545730589 0.555385346 3.1233575
8.447454025 8.310423509 3.106280448 2.634451595
8.335482586 8.30943967 -1.403371598 0.624032175
8.282805609 8.368336416 3.9310322 3.177076259
8.279597687 8.428005703 0.641426753 0.939478116
8.229745683 8.200501627 2.258755369 2.701196642
8.126768762 8.059763488 1.837865144 2.486757294
8.101967269 8.336785402 -1.135635121 0.306806152
8.052407725 8.140960587 4.662441162 4.278214037
8.022390481 8.105072926 4.775510278 4.642266863
8.003116186 8.049563649 1.797694202 2.19949349
7.980948745 8.09804122 3.130369478 4.250882656
7.971127611 8.493942331 4.322737195 4.301231368
7.933155211 7.898542834 3.857016244 4.270311171
7.865793873 8.05688693 2.767287093 3.017083287
7.846903494 5.738651999 -0.840454455 -0.398013183
7.82511545 7.919739955 4.320897283 4.496234486
7.808656437 7.942893203 3.977795405 4.215416886
7.725665001 7.304979806 3.622565208 4.175564856
7.705039007 7.931702059 -0.11347905 0.5216073
7.69703759 7.506909766 2.646655822 -0.768883901
7.694234499 6.691689871 1.918105181 2.119538354
7.666243489 7.709779358 3.198913765 4.7106177
7.583007426 7.239363266 4.258370146 4.058794228
7.530903134 4.577606281 2.457931446 3.637338312
7.478215649 6.939567139 3.500028783 2.554199466
7.430646653 7.919688706 2.756945148 3.199386421
7.370497323 8.619761911 1.183268455 -2.544215274
7.309334655 6.819438323 -1.568725348 -0.126284076
7.289989796 7.2577753 3.647997151 3.897793345
7.220241201 6.620997473 3.635034582 3.151476436
7.164416075 6.502617093 1.202963591 1.114890147
7.15220671 7.443608079 3.599481403 3.697274504
7.131013073 6.689842781 1.406882141 -1.610108205
6.921368598 7.281865676 2.796195965 0.88813999
6.915854907 6.030820633 -0.819247143 -0.37680587
6.880140035 7.755396943 -2.031550746 0.732818621
6.85809537 7.620965108 -0.84663303 -1.404191758
6.755384605 6.032827517 1.166133423 2.15606249
6.728684128 6.72804988 0.832590202 -0.309931026
6.648937066 7.378318864 -0.966088531 -0.523647258
6.588908737 6.081353739 1.925699606 1.721777833
6.581131386 8.063111454 -0.263888355 0.663979745
6.580138527 6.596876336 2.159909815 3.559282366
6.577413098 6.087516766 1.967841931 1.466866732
6.538027568 7.042571711 1.824951825 1.39292398
6.46751363 7.858579428 0.743382698 1.185823971
6.450954582 7.664926157 4.16033381 3.843783182
6.418031776 6.258608648 1.194643245 2.959012613
6.385113535 4.919879257 1.624920504 1.819434263
6.360742641 5.9804708 0.962675579 1.142082446
6.315569323 6.646770394 -0.319281253 0.275163113
6.254538115 7.515232641 -1.993633516 -1.551192244
6.242685851 5.549256125 -0.892346806 1.424563585
6.168150034 6.260027925 -0.220394254 0.222047018
6.081960583 6.065803707 1.907654723 0.310567632
6.034207452 6.047743735 0.698201358 -2.181285465
5.839658068 6.612796142 2.264496931 2.952050702
5.750772237 6.260875905 -0.257348307 0.185092965
5.672122105 5.969377125 -0.298196406 -0.270792632
5.588561977 5.186128487 0.985910224 1.961783696
5.550126495 5.761634572 1.724421897 1.581900669
5.44706551 6.297539878 0.464035947 0.643442814
5.325874331 5.957284296 2.43030761 -1.214713959
5.144123894 5.615753415 2.019075327 -0.074536301
5.142946665 4.553514659 0.08591652 0.528357793
5.061295577 5.394053304 1.889460958 -1.712491889
4.981085279 4.445385257 -1.16905427 -0.726612997
4.96742036 6.107311729 2.438769188 1.106770161
4.917581562 3.683524134 -2.298647177 -1.856205905
4.857606037 5.555699423 -2.892446353 -0.450005081
4.853569631 5.580248394 1.254122681 1.318052331
4.32234264 5.722263391 1.406668345 1.112144024
4.296553758 4.531022983 -0.377147747 1.065293525
4.29642442 4.901685321 0.271815754 1.003763643
4.112470693 4.053208716 0.023731689 -1.118789539
3.955063806 4.415414439 -1.492756292 -2.63527752
3.709022735 2.820577027 -0.714135308 -0.271694035
3.61791878 4.20602496 -1.70214577 -1.259704497
3.583309137 5.873022737 0.111241494 -1.031279734
3.346616758 5.45497975 1.026552208 1.053955982
3.175129951 4.153786628 0.768650649 0.500598539
3.083416287 3.593519955 -1.154186103 0.28825517
2.677217155 4.556554633 -2.057884894 -1.615443622
2.617117261 4.449149024 -2.620485129 0.143884238
2.347746512 2.402170696 -0.387355538 -1.359951764
1.81586527 2.459235469 -0.82903897 -1.524101222
-0.551324579 3.602635279 -1.701464128 -1.259022855
Antigen Company
NANOG Peprotech
BRACHYURY(T) R&D
OCT4 SantaCruz
OCT4 BD Biosciences
TFAP2C SantaCruz
TFAP2C R&D
SOX2 SantaCruz
SOX2 Abcam
SOX17 R&D
BLIMP1 eBioscience
Sda/GM2(CT1) in house (Klisch et al ., Reproduction (2011))
Phospho-Smad1/Smad5/Smad8 EMD Millipore
FOXA2 Cell Signaling Technology
HA-tag Cell Signaling Technology
HA-tag Biolegend
Myc-tag Cell Signaling Technology
5mC Eurogentec
5hmC Active Motif
G9a Cell Signaling
H3K9me2 Active Motif
Tet1 GeneTex
UHRF1 Active Motif
DNMT3A Santa Cruz
RFP (for tdTomato) chromotek
HAND1 R&D
FOXF1 Abcam
Cat No. Dilution
500-P236 1:300
AF2085 1:300
sc-8628 1:300
611203 1:250
sc-8977 1:300
AF5059 1:500
sc-17320 1:300
ab97959 1:200
AF1924 1:300
14-5963 1:50
1:50
AB3848 1:300
8186P 1:300
3724S 1:500
901501 1:500
2276S 1:4000
BI-MECY-0100 1:500
 39791 1:1500
#3306 1:100
39376 1:1500
GTX627420 1:200
61341 1:300
sc-20703 1:500
5f8-100 1:500
AF3168 1:250
ab168383 1:250
Gene Forward (5'→3')
GAPDH CGCTTCGCTCTCTGCTCCTCCTGT
OCT3/4 GCTGGAGCAAAACCCGGAGG
NANOG TGCTGAGATGCCTCACACGGA
SOX2 ACACCAA TCCCA TCCACACT
KLF4 AGCCTAAATGATGGTGCTTGGT
TFCP2L1 AGCTCAAAGTTGTCCTACTGCC
SOX17(total) GAGCCAAGGGCGAGTCCCGTA
SOX17(endo) CCTGGGTTTTTGTTGTTGCT
BLIMP1(total) CTACCCTTATCCCGGAGAGC
BLIMP1(endo) CGGGGAGAATGTGGACTGGGTAGAG
TFAP2C ATTAAGAGGATGCTGGGCTCTG
NANOS3 CCCGAAACTCGGCAGGCAAGA
FOXA1 AAGGCATACGAACAGGCACTG
FOXA2 ACCCGGTTTTATCCCTTGAATC
HNF1B CAATCCACTCTCAGGAGGCG
T AGCCAAAGACAATCAGCAGAAA
MIXL1 TGCTTTCAAAACACTCGAGGAC
GSC GTCGAGAAAGAGGAACGAGGAG
EVX1 CAAATCCTCACTCCCACACTCA
EOMES CAACATAAACGGACTCAATCCCA
TBX6 AAGTACCAACCCCGCATACA
MESP1 GTGCTGGCTCTGTTGGAGA
MESP2 AGCTTGGGTGCCTCCTTATT
SNAI1 CACTATGCCGCGCTCTTTC
SNAI2 CAGACCCTGGTTGCTTCAA
Reverse (5'→3') Reference
GGTGACCAGGCGCCCAATACGA Irie et al., Cell (2015)
TCGGCCTGTGTATATCCCAGGGTG Irie et al., Cell (2015)
TGACCGGGACCTTGTCTTCCTT Irie et al., Cell (2015)
CCTCCCCAGGTTTTCTCTGT Irie et al., Cell (2015)
CCTTGTCAAAGTATGCAGCAGT Sasaki et al., Cell Stem Cell (2015)
TTCTAACCCAAGCACAGATCCC Sasaki et al., Cell Stem Cell (2015)
CCTTCCACGACTTGCCCAGCAT Irie et al., Cell (2015)
CCCCAAACTGTTCAAGTGG
GGACATTCTTTGGGCAGAGT
CTGGAGTTACACTTGGGGGCAGC Irie et al., Cell (2015)
CACTGTACTGCACACTCACCTT Sasaki et al., Cell Stem Cell (2015)
AAGGCTCAGACTTCCCGGCAC Irie et al., Cell (2015)
TACACACCTTGGTAGTACGCC Loh et al., Cell Stem Cell (2014)
ATACAACCTGCAACCAGACAGG Sasaki et al., Cell Stem Cell (2015)
ATCGTGGGAGAGGCATTGTG Irie et al., Cell (2015)
CACAAAAGGAGGGGCTTCACTA Sasaki et al., Cell Stem Cell (2015)
GAGTGATCGAAGTAACAGGTGC Sasaki et al., Cell Stem Cell (2015)
AAATACTACGGTGGGGGCTAGT Sasaki et al., Cell Stem Cell (2015)
GAAGAACCACTCCCTCTCAGTC Sasaki et al., Cell Stem Cell (2015)
ACCACCTCTACGAACACATTGT Loh et al., Cell Stem Cell (2014)
TAGGCTGTCACGGAGATGAA Loh et al., Cell Stem Cell (2014)
CTCGGTGCTCACAGAGACG
TGCTTCCCTGAAAGACATCA Loh et al., Cell Stem Cell (2014)
GGTCGTAGGGCTGCTGGAA Unternaehrer et al., Stem Cell Reports (2014)
TGACCTGTCTGCAAATGCTC ???
